Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for secondary brain injury after spontaneous intracerebral hemorrhage
NL-OMON52254Phase 2Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2022
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of anakinra in intracerebral hemorrhage (ICH) and brain hemorrhage (ICH) (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Perihematomal edema extension distance at day 7 and Dose-response on edema extension distance. Started Sep 2022; status: recruiting.
02
Drugs
anakinra
03
Conditions
intracerebral hemorrhage (ICH)brain hemorrhage (ICH)
Beyond the preview
Go deeper on NL-OMON52254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52254.